RECORD // Company
Lb Pharmaceuticals Inc
Formerly: LB PHARMACEUTICALS INC.
Built 2026-11-22T00:17:03Z from public sources · JSON · Open the company profile
ASK THE RECORDS
Ask
COMPANY
Records for this company (1 joined by official identifier)
Every record below is joined to this company by a hard identifier: its SEC registrant record or its GLEIF ownership tree. Each line says how. Built 2026-11-18 13:42:42. Beta: records that match only by name are held apart until name matching is verified.
SEC EDGAR (1)
- LB PHARMACEUTICALS INC · the SEC registrant record of this company
Matched by name only, not merged (5)
These records carry the same exact name as this company, but a name alone is not proof, so Seraphix holds them apart until name matching is verified (score due 11-21).
- LB Pharmaceuticals Inc. · Ctgov · same registered legal name as 'LB PHARMACEUTICALS INC' Possible match based on name, not a shared identifier. Compare the records. Compare
- LB PHARMACEUTICALS INC. · East licences · same registered legal name as 'LB PHARMACEUTICALS INC' Possible match based on name, not a shared identifier. Compare the records. Compare
- LB PHARMACEUTICALS INC. · East licences · same registered legal name as 'LB PHARMACEUTICALS INC' Possible match based on name, not a shared identifier. Compare the records. Compare
- LB PHARMACEUTICALS INC. · East licences · same registered legal name as 'LB PHARMACEUTICALS INC' Possible match based on name, not a shared identifier. Compare the records. Compare
- LB PHARMACEUTICALS INC · Ny corps · same registered legal name as 'LB PHARMACEUTICALS INC' Possible match based on name, not a shared identifier. Compare the records. Compare
2 VALUES · 10-Q · EACH LINKS TO ITS FILING
Latest quarter
Latest report: 10-Q for the period ended 2026-09-30, filed 2026-11-05 · accession 0001193125-26-449994
| Item | Value | Period | Form | Filed | Accession | Report | |
|---|---|---|---|---|---|---|---|
| Net income (loss) | $-59,066,000 | 3 months ended 2026-09-30 | 10-Q | 2026-11-05 | 0001193125-26-449994 | 2026-11-22 00:17 UTC | Report an error |
| Cash and cash equivalents | $215,075,000 | at 2026-09-30 | 10-Q | 2026-11-05 | 0001193125-26-449994 | 2026-11-22 00:17 UTC | Report an error |
Negative as reported in the filing.
Not in this report's XBRL: Revenue, Interest expense.
Values as filed in XBRL (SEC company facts); quarterly values are the filer's 3-month figures, never derived.
IDS
Identifiers
- SEC CIK
- 0001691082
- Ticker
- LBRX
- CUSIP
- 50180M108
- Record ID
- sx:sec:0001691082
OTHER SITES · YOUR CLICK · THEY SHOW THEIR OWN DATA
Open in
Open in…
Price and chart
News
Analyst estimates and earnings
Institutional holders
Short interest
Official social
Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.
28 FACTS · EACH LINKS TO ITS FILING
Facts
| Fact | Value | As of | Source | Retrieved | Report |
|---|---|---|---|---|---|
| SEC entity type | operating | 2026-11-16 | SEC EDGAR company profile | 2026-11-22 00:17 UTC | Report an error |
| SIC industry | 2834 Pharmaceutical Preparations | 2026-11-16 | SEC EDGAR company profile | 2026-11-22 00:17 UTC | Report an error |
| State of incorporation | DE | 2026-11-16 | SEC EDGAR company profile | 2026-11-22 00:17 UTC | Report an error |
| Fiscal year end (MMDD) | 1231 | 2026-11-16 | SEC EDGAR company profile | 2026-11-22 00:17 UTC | Report an error |
| Business address | 575 MADISON AVENUE, NEW YORK, NY, 10022 | 2026-11-16 | SEC EDGAR company profile | 2026-11-22 00:17 UTC | Report an error |
| Exchanges | Nasdaq | 2026-11-16 | SEC EDGAR company profile | 2026-11-22 00:17 UTC | Report an error |
| Net income (loss) (fiscal year ended 2025-12-31) | $-25,205,000 | 2025-12-31 | 10-K, XBRL NetIncomeLoss | 2026-11-22 00:17 UTC | Report an error |
| Total assets (at 2025-12-31) | $312,934,000 | 2025-12-31 | 10-K, XBRL Assets | 2026-11-22 00:17 UTC | Report an error |
| Stockholders' equity (at 2025-12-31) | $301,310,000 | 2025-12-31 | 10-K, XBRL StockholdersEquity | 2026-11-22 00:17 UTC | Report an error |
| Cash and cash equivalents (at 2025-12-31) | $250,173,000 | 2025-12-31 | 10-K, XBRL CashAndCashEquivalentsAtCarryingValue | 2026-11-22 00:17 UTC | Report an error |
| Operating cash flow (fiscal year ended 2025-12-31) | $-35,208,000 | 2025-12-31 | 10-K, XBRL NetCashProvidedByUsedInOperatingActivities | 2026-11-22 00:17 UTC | Report an error |
| Capital expenditures (property, plant and equipment) (fiscal year ended 2025-12-31) | $52,000 | 2025-12-31 | 10-K, XBRL PaymentsToAcquirePropertyPlantAndEquipment | 2026-11-22 00:17 UTC | Report an error |
| Operating lease liabilities (at 2025-12-31) | $3,569,000 | 2025-12-31 | 10-K, XBRL OperatingLeaseLiability | 2026-11-22 00:17 UTC | Report an error |
| Form D total offering amount (D/A filed 2024-01-10) | $110,730,354 | 2024-01-10 | D/A | 2026-11-22 00:17 UTC | Report an error |
| Form D total amount sold (D/A filed 2024-01-10) | $110,730,354 | 2024-01-10 | D/A | 2026-11-22 00:17 UTC | Report an error |
| Form D industry group | Pharmaceuticals | 2024-01-10 | D/A | 2026-11-22 00:17 UTC | Report an error |
| Form D revenue range | Decline to Disclose | 2024-01-10 | D/A | 2026-11-22 00:17 UTC | Report an error |
| Form D date of first sale | 2023-08-29 | 2024-01-10 | D/A | 2026-11-22 00:17 UTC | Report an error |
| Largest institutional holder #1 (13F as filed): Deep Track Capital, LP | $108,815,254 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 00:17 UTC | Report an error |
| Largest institutional holder #2 (13F as filed): BlackRock, Inc. | $88,741,868 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 00:17 UTC | Report an error |
| Largest institutional holder #3 (13F as filed): RA CAPITAL MANAGEMENT, L.P. | $71,680,243 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 00:17 UTC | Report an error |
| Largest institutional holder #4 (13F as filed): Nantahala Capital Management, LLC | $68,343,350 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 00:17 UTC | Report an error |
| Largest institutional holder #5 (13F as filed): Trails Edge Capital Partners, LP | $49,429,679 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 00:17 UTC | Report an error |
| Largest institutional holder #6 (13F as filed): JPMORGAN CHASE & CO | $48,871,644 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 00:17 UTC | Report an error |
| Largest institutional holder #7 (13F as filed): Commodore Capital LP | $48,682,500 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 00:17 UTC | Report an error |
| Largest institutional holder #8 (13F as filed): TCG Crossover Management, LLC | $46,972,446 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 00:17 UTC | Report an error |
| Largest institutional holder #9 (13F as filed): Caligan Partners LP | $46,672,562 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 00:17 UTC | Report an error |
| Largest institutional holder #10 (13F as filed): Spruce Street Capital LP | $44,663,240 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 00:17 UTC | Report an error |
EVERY DATED RECORD, NEWEST FIRST
Timeline
- 2026-11-05 Filing 10-Q filed
- 2026-11-05 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-10-05 Filing EFFECT filed
- 2026-10-01 Filing POS AM filed
- 2026-10-01 Filing S-3ASR filed
- 2026-09-15 Filing 424B3 filed
- 2026-09-15 Filing 8-K filed: Item 5.02 officer or director change; Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-09-03 Filing 424B3 filed
- 2026-09-03 Filing 8-K filed: Item 5.02 officer or director change; Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-08-11 Filing 424B3 filed
- 2026-08-11 Filing 10-Q filed
- 2026-08-11 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-07-29 Filing 424B3 filed
- 2026-07-29 Filing 8-K filed: Item 1.01 material agreement; Item 3.02 unregistered equity sale; Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-07-22 Filing 424B3 filed
- 2026-07-22 Filing 8-K filed: Item 8.01 other event; Item 9.01 exhibits
- 2026-06-10 Filing 424B3 filed
- 2026-06-10 Filing 8-K filed: Item 5.02 officer or director change; Item 9.01 exhibits
- 2026-06-09 Filing 424B3 filed
- 2026-06-09 Filing 8-K filed: Item 5.07 shareholder vote
- 2026-05-12 Filing 424B3 filed
- 2026-05-12 Filing 10-Q filed
- 2026-05-12 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-04-23 Filing ARS filed
- 2026-04-23 Filing DEFA14A filed
WHAT IS NOT HERE
Gaps
- Court records: not covered yet (expected 11-19).
- No EIN on the SEC filing, so no Form 990 lookup
- USAspending: no recipient whose SAM legal name and address match this SEC filer
SOURCES AND LICENSE
Sources
- SEC EDGAR: checked · 2026-11-22T00:17:04Z
- Propublica 990: checked, nothing found · 2026-11-22T00:17:04Z
- SEC 13F holdings: checked · 2026-11-22T00:17:04Z
- USAspending: checked, nothing found · 2026-11-22T00:17:06Z
CC BY 4.0 -- credit Seraphix Systems.
API
Use this record
Records are free to read and reuse under CC BY 4.0 -- credit Seraphix Systems. The same records as JSON: GET /v1/search?q= and GET /v1/record/<id> (without a key, up to 50 record lookups a day per visitor). No key: single records, pages, feeds and bulk files are free; cross-company search and the live stream cost $0.002 a call via x402. Free key: 100 calls a month, no card. Get a free key or a paid key; send Authorization: Bearer <key>.